0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Testosterone Replacement Injectables Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-5N17091
Home | Market Reports | Health| Men s Health
Global Testosterone Replacement Injectables Market Research Report 2024
BUY CHAPTERS

Global Testosterone Replacement Injectables Market Research Report 2026

Code: QYRE-Auto-5N17091
Report
2026-04-10
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Testosterone Replacement Injectables Market Size

The global Testosterone Replacement Injectables market was valued at US$ 1425 million in 2025 and is anticipated to reach US$ 1884 million by 2032, at a CAGR of 4.1% from 2026 to 2032.

Testosterone Replacement Injectables Market

Testosterone Replacement Injectables Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Testosterone Replacement Injectables competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Testosterone replacement therapy (TRT) is a medical intervention designed to address low testosterone levels in individuals, particularly men. Testosterone, a key male sex hormone, plays a crucial role in various bodily functions, including the development of secondary sexual characteristics, maintaining bone density, muscle mass, and energy levels. When testosterone levels decline due to aging, medical conditions, or other factors, individuals experience symptoms such as fatigue, reduced libido, mood swings, and diminished cognitive function. Testosterone replacement therapy aims to restore testosterone levels to normal ranges, alleviating these symptoms and potentially improving overall well-being. Injection is the common methods of administering testosterone replacement therapy.
According to 2023 report by National Library of Medicine it was reported that hypogonadism occurs in 19% of men in their 60s, 28% of men in their 70s, and 49% of men in their 80s. In addition, according to the World Health Organization, it was reported that by 2030, 1 in 6 people in the world are expected to be aged 60 years or over. Furthermore, according to a 2023 report by the National Library of Medicine, it was reported that hypogonadism is common in geriatric patients.
This report delivers a comprehensive overview of the global Testosterone Replacement Injectables market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Testosterone Replacement Injectables. The Testosterone Replacement Injectables market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Testosterone Replacement Injectables market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Testosterone Replacement Injectables manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Testosterone Replacement Injectables Market Report

Report Metric Details
Report Name Testosterone Replacement Injectables Market
Accounted market size in 2025 US$ 1425 million
Forecasted market size in 2032 US$ 1884 million
CAGR 4.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Testosterone Undecanoate
  • Testosterone Cypionate
  • Testosterone Enanthate
  • Others
by Application
  • Hospital
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Marius Pharmaceuticals, Insud Pharma S.L, AbbVie Inc, Acrux Ltd, Besins Healthcare SA, Pfizer Inc, Acerus Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc, Biote Medical LLC, Endo International Plc, Eli lilly, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Testosterone Replacement Injectables manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Testosterone Replacement Injectables sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Testosterone Replacement Injectables Market growing?

Ans: The Testosterone Replacement Injectables Market witnessing a CAGR of 4.1% during the forecast period 2026-2032.

What is the Testosterone Replacement Injectables Market size in 2032?

Ans: The Testosterone Replacement Injectables Market size in 2032 will be US$ 1884 million.

Who are the main players in the Testosterone Replacement Injectables Market report?

Ans: The main players in the Testosterone Replacement Injectables Market are Marius Pharmaceuticals, Insud Pharma S.L, AbbVie Inc, Acrux Ltd, Besins Healthcare SA, Pfizer Inc, Acerus Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc, Biote Medical LLC, Endo International Plc, Eli lilly, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin

What are the Application segmentation covered in the Testosterone Replacement Injectables Market report?

Ans: The Applications covered in the Testosterone Replacement Injectables Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Testosterone Replacement Injectables Market report?

Ans: The Types covered in the Testosterone Replacement Injectables Market report are Testosterone Undecanoate, Testosterone Cypionate, Testosterone Enanthate, Others

1 Testosterone Replacement Injectables Market Overview
1.1 Product Definition
1.2 Testosterone Replacement Injectables by Type
1.2.1 Global Testosterone Replacement Injectables Market Value by Type: 2025 vs 2032
1.2.2 Testosterone Undecanoate
1.2.3 Testosterone Cypionate
1.2.4 Testosterone Enanthate
1.2.5 Others
1.3 Testosterone Replacement Injectables by Application
1.3.1 Global Testosterone Replacement Injectables Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Testosterone Replacement Injectables Market Size Estimates and Forecasts
1.4.1 Global Testosterone Replacement Injectables Revenue 2021–2032
1.4.2 Global Testosterone Replacement Injectables Sales 2021–2032
1.4.3 Global Testosterone Replacement Injectables Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Testosterone Replacement Injectables Market Competition by Manufacturers
2.1 Global Testosterone Replacement Injectables Sales Market Share by Manufacturers (2021–2026)
2.2 Global Testosterone Replacement Injectables Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Testosterone Replacement Injectables Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Testosterone Replacement Injectables, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Testosterone Replacement Injectables, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Testosterone Replacement Injectables, Product Types and Applications
2.7 Global Key Manufacturers of Testosterone Replacement Injectables, Date of Entry into the Industry
2.8 Global Testosterone Replacement Injectables Market Competitive Situation and Trends
2.8.1 Global Testosterone Replacement Injectables Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Testosterone Replacement Injectables Players Market Share by Revenue
2.8.3 Global Testosterone Replacement Injectables Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Testosterone Replacement Injectables Market Scenario by Region
3.1 Global Testosterone Replacement Injectables Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Testosterone Replacement Injectables Sales by Region: 2021–2032
3.2.1 Global Testosterone Replacement Injectables Sales by Region: 2021–2026
3.2.2 Global Testosterone Replacement Injectables Sales by Region: 2027–2032
3.3 Global Testosterone Replacement Injectables Revenue by Region: 2021–2032
3.3.1 Global Testosterone Replacement Injectables Revenue by Region: 2021–2026
3.3.2 Global Testosterone Replacement Injectables Revenue by Region: 2027–2032
3.4 North America Testosterone Replacement Injectables Market Facts & Figures by Country
3.4.1 North America Testosterone Replacement Injectables Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Testosterone Replacement Injectables Sales by Country (2021–2032)
3.4.3 North America Testosterone Replacement Injectables Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Testosterone Replacement Injectables Market Facts & Figures by Country
3.5.1 Europe Testosterone Replacement Injectables Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Testosterone Replacement Injectables Sales by Country (2021–2032)
3.5.3 Europe Testosterone Replacement Injectables Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Replacement Injectables Market Facts & Figures by Region
3.6.1 Asia Pacific Testosterone Replacement Injectables Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Testosterone Replacement Injectables Sales by Region (2021–2032)
3.6.3 Asia Pacific Testosterone Replacement Injectables Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Testosterone Replacement Injectables Market Facts & Figures by Country
3.7.1 Latin America Testosterone Replacement Injectables Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Testosterone Replacement Injectables Sales by Country (2021–2032)
3.7.3 Latin America Testosterone Replacement Injectables Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Testosterone Replacement Injectables Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Replacement Injectables Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Testosterone Replacement Injectables Sales by Country (2021–2032)
3.8.3 Middle East and Africa Testosterone Replacement Injectables Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Replacement Injectables Sales by Type (2021–2032)
4.1.1 Global Testosterone Replacement Injectables Sales by Type (2021–2026)
4.1.2 Global Testosterone Replacement Injectables Sales by Type (2027–2032)
4.1.3 Global Testosterone Replacement Injectables Sales Market Share by Type (2021–2032)
4.2 Global Testosterone Replacement Injectables Revenue by Type (2021–2032)
4.2.1 Global Testosterone Replacement Injectables Revenue by Type (2021–2026)
4.2.2 Global Testosterone Replacement Injectables Revenue by Type (2027–2032)
4.2.3 Global Testosterone Replacement Injectables Revenue Market Share by Type (2021–2032)
4.3 Global Testosterone Replacement Injectables Price by Type (2021–2032)
5 Segment by Application
5.1 Global Testosterone Replacement Injectables Sales by Application (2021–2032)
5.1.1 Global Testosterone Replacement Injectables Sales by Application (2021–2026)
5.1.2 Global Testosterone Replacement Injectables Sales by Application (2027–2032)
5.1.3 Global Testosterone Replacement Injectables Sales Market Share by Application (2021–2032)
5.2 Global Testosterone Replacement Injectables Revenue by Application (2021–2032)
5.2.1 Global Testosterone Replacement Injectables Revenue by Application (2021–2026)
5.2.2 Global Testosterone Replacement Injectables Revenue by Application (2027–2032)
5.2.3 Global Testosterone Replacement Injectables Revenue Market Share by Application (2021–2032)
5.3 Global Testosterone Replacement Injectables Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Marius Pharmaceuticals
6.1.1 Marius Pharmaceuticals Company Information
6.1.2 Marius Pharmaceuticals Description and Business Overview
6.1.3 Marius Pharmaceuticals Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Marius Pharmaceuticals Testosterone Replacement Injectables Product Portfolio
6.1.5 Marius Pharmaceuticals Recent Developments/Updates
6.2 Insud Pharma S.L
6.2.1 Insud Pharma S.L Company Information
6.2.2 Insud Pharma S.L Description and Business Overview
6.2.3 Insud Pharma S.L Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Insud Pharma S.L Testosterone Replacement Injectables Product Portfolio
6.2.5 Insud Pharma S.L Recent Developments/Updates
6.3 AbbVie Inc
6.3.1 AbbVie Inc Company Information
6.3.2 AbbVie Inc Description and Business Overview
6.3.3 AbbVie Inc Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Inc Testosterone Replacement Injectables Product Portfolio
6.3.5 AbbVie Inc Recent Developments/Updates
6.4 Acrux Ltd
6.4.1 Acrux Ltd Company Information
6.4.2 Acrux Ltd Description and Business Overview
6.4.3 Acrux Ltd Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Acrux Ltd Testosterone Replacement Injectables Product Portfolio
6.4.5 Acrux Ltd Recent Developments/Updates
6.5 Besins Healthcare SA
6.5.1 Besins Healthcare SA Company Information
6.5.2 Besins Healthcare SA Description and Business Overview
6.5.3 Besins Healthcare SA Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Besins Healthcare SA Testosterone Replacement Injectables Product Portfolio
6.5.5 Besins Healthcare SA Recent Developments/Updates
6.6 Pfizer Inc
6.6.1 Pfizer Inc Company Information
6.6.2 Pfizer Inc Description and Business Overview
6.6.3 Pfizer Inc Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Pfizer Inc Testosterone Replacement Injectables Product Portfolio
6.6.5 Pfizer Inc Recent Developments/Updates
6.7 Acerus Pharmaceuticals Corporation
6.7.1 Acerus Pharmaceuticals Corporation Company Information
6.7.2 Acerus Pharmaceuticals Corporation Description and Business Overview
6.7.3 Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Product Portfolio
6.7.5 Acerus Pharmaceuticals Corporation Recent Developments/Updates
6.8 Amneal Pharmaceuticals Inc
6.8.1 Amneal Pharmaceuticals Inc Company Information
6.8.2 Amneal Pharmaceuticals Inc Description and Business Overview
6.8.3 Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Product Portfolio
6.8.5 Amneal Pharmaceuticals Inc Recent Developments/Updates
6.9 Biote Medical LLC
6.9.1 Biote Medical LLC Company Information
6.9.2 Biote Medical LLC Description and Business Overview
6.9.3 Biote Medical LLC Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Biote Medical LLC Testosterone Replacement Injectables Product Portfolio
6.9.5 Biote Medical LLC Recent Developments/Updates
6.10 Endo International Plc
6.10.1 Endo International Plc Company Information
6.10.2 Endo International Plc Description and Business Overview
6.10.3 Endo International Plc Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Endo International Plc Testosterone Replacement Injectables Product Portfolio
6.10.5 Endo International Plc Recent Developments/Updates
6.11 Eli lilly
6.11.1 Eli lilly Company Information
6.11.2 Eli lilly Description and Business Overview
6.11.3 Eli lilly Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Eli lilly Testosterone Replacement Injectables Product Portfolio
6.11.5 Eli lilly Recent Developments/Updates
6.12 Actavis (Allergan)
6.12.1 Actavis (Allergan) Company Information
6.12.2 Actavis (Allergan) Description and Business Overview
6.12.3 Actavis (Allergan) Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Actavis (Allergan) Testosterone Replacement Injectables Product Portfolio
6.12.5 Actavis (Allergan) Recent Developments/Updates
6.13 Bayer
6.13.1 Bayer Company Information
6.13.2 Bayer Description and Business Overview
6.13.3 Bayer Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Bayer Testosterone Replacement Injectables Product Portfolio
6.13.5 Bayer Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Company Information
6.14.2 Novartis Description and Business Overview
6.14.3 Novartis Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Novartis Testosterone Replacement Injectables Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Teva
6.15.1 Teva Company Information
6.15.2 Teva Description and Business Overview
6.15.3 Teva Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Teva Testosterone Replacement Injectables Product Portfolio
6.15.5 Teva Recent Developments/Updates
6.16 Mylan
6.16.1 Mylan Company Information
6.16.2 Mylan Description and Business Overview
6.16.3 Mylan Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Mylan Testosterone Replacement Injectables Product Portfolio
6.16.5 Mylan Recent Developments/Updates
6.17 Upsher-Smith
6.17.1 Upsher-Smith Company Information
6.17.2 Upsher-Smith Description and Business Overview
6.17.3 Upsher-Smith Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Upsher-Smith Testosterone Replacement Injectables Product Portfolio
6.17.5 Upsher-Smith Recent Developments/Updates
6.18 Ferring Pharmaceuticals
6.18.1 Ferring Pharmaceuticals Company Information
6.18.2 Ferring Pharmaceuticals Description and Business Overview
6.18.3 Ferring Pharmaceuticals Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Ferring Pharmaceuticals Testosterone Replacement Injectables Product Portfolio
6.18.5 Ferring Pharmaceuticals Recent Developments/Updates
6.19 Kyowa Kirin
6.19.1 Kyowa Kirin Company Information
6.19.2 Kyowa Kirin Description and Business Overview
6.19.3 Kyowa Kirin Testosterone Replacement Injectables Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Kyowa Kirin Testosterone Replacement Injectables Product Portfolio
6.19.5 Kyowa Kirin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Replacement Injectables Industry Chain Analysis
7.2 Testosterone Replacement Injectables Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Replacement Injectables Production Mode & Process Analysis
7.4 Testosterone Replacement Injectables Sales and Marketing
7.4.1 Testosterone Replacement Injectables Sales Channels
7.4.2 Testosterone Replacement Injectables Distributors
7.5 Testosterone Replacement Injectables Customer Analysis
8 Testosterone Replacement Injectables Market Dynamics
8.1 Testosterone Replacement Injectables Industry Trends
8.2 Testosterone Replacement Injectables Market Drivers
8.3 Testosterone Replacement Injectables Market Challenges
8.4 Testosterone Replacement Injectables Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Testosterone Replacement Injectables Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Testosterone Replacement Injectables Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Testosterone Replacement Injectables Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Testosterone Replacement Injectables Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Testosterone Replacement Injectables Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Testosterone Replacement Injectables Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Testosterone Replacement Injectables Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Testosterone Replacement Injectables Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Testosterone Replacement Injectables, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Testosterone Replacement Injectables, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Testosterone Replacement Injectables, Product Types and Applications
 Table 12. Global Key Manufacturers of Testosterone Replacement Injectables, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Testosterone Replacement Injectables Companies by Tier (Tier 1, Tier 2, Tier 3), based on Testosterone Replacement Injectables Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Testosterone Replacement Injectables Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Testosterone Replacement Injectables Sales by Region (K Units), 2021–2026
 Table 18. Global Testosterone Replacement Injectables Sales Market Share by Region (2021–2026)
 Table 19. Global Testosterone Replacement Injectables Sales by Region (K Units), 2027–2032
 Table 20. Global Testosterone Replacement Injectables Sales Market Share by Region (2027–2032)
 Table 21. Global Testosterone Replacement Injectables Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Testosterone Replacement Injectables Revenue Market Share by Region (2021–2026)
 Table 23. Global Testosterone Replacement Injectables Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Testosterone Replacement Injectables Revenue Market Share by Region (2027–2032)
 Table 25. North America Testosterone Replacement Injectables Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Testosterone Replacement Injectables Sales by Country (K Units), 2021–2026
 Table 27. North America Testosterone Replacement Injectables Sales by Country (K Units), 2027–2032
 Table 28. North America Testosterone Replacement Injectables Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Testosterone Replacement Injectables Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Testosterone Replacement Injectables Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Testosterone Replacement Injectables Sales by Country (K Units), 2021–2026
 Table 32. Europe Testosterone Replacement Injectables Sales by Country (K Units), 2027–2032
 Table 33. Europe Testosterone Replacement Injectables Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Testosterone Replacement Injectables Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Testosterone Replacement Injectables Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Testosterone Replacement Injectables Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Testosterone Replacement Injectables Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Testosterone Replacement Injectables Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Testosterone Replacement Injectables Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Testosterone Replacement Injectables Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Testosterone Replacement Injectables Sales by Country (K Units), 2021–2026
 Table 42. Latin America Testosterone Replacement Injectables Sales by Country (K Units), 2027–2032
 Table 43. Latin America Testosterone Replacement Injectables Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Testosterone Replacement Injectables Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Testosterone Replacement Injectables Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Testosterone Replacement Injectables Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Testosterone Replacement Injectables Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Testosterone Replacement Injectables Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Testosterone Replacement Injectables Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Testosterone Replacement Injectables Sales (K Units) by Type (2021–2026)
 Table 51. Global Testosterone Replacement Injectables Sales (K Units) by Type (2027–2032)
 Table 52. Global Testosterone Replacement Injectables Sales Market Share by Type (2021–2026)
 Table 53. Global Testosterone Replacement Injectables Sales Market Share by Type (2027–2032)
 Table 54. Global Testosterone Replacement Injectables Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Testosterone Replacement Injectables Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Testosterone Replacement Injectables Revenue Market Share by Type (2021–2026)
 Table 57. Global Testosterone Replacement Injectables Revenue Market Share by Type (2027–2032)
 Table 58. Global Testosterone Replacement Injectables Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Testosterone Replacement Injectables Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Testosterone Replacement Injectables Sales (K Units) by Application (2021–2026)
 Table 61. Global Testosterone Replacement Injectables Sales (K Units) by Application (2027–2032)
 Table 62. Global Testosterone Replacement Injectables Sales Market Share by Application (2021–2026)
 Table 63. Global Testosterone Replacement Injectables Sales Market Share by Application (2027–2032)
 Table 64. Global Testosterone Replacement Injectables Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Testosterone Replacement Injectables Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Testosterone Replacement Injectables Revenue Market Share by Application (2021–2026)
 Table 67. Global Testosterone Replacement Injectables Revenue Market Share by Application (2027–2032)
 Table 68. Global Testosterone Replacement Injectables Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Testosterone Replacement Injectables Price (US$/Unit) by Application (2027–2032)
 Table 70. Marius Pharmaceuticals Company Information
 Table 71. Marius Pharmaceuticals Description and Business Overview
 Table 72. Marius Pharmaceuticals Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Marius Pharmaceuticals Testosterone Replacement Injectables Product
 Table 74. Marius Pharmaceuticals Recent Developments/Updates
 Table 75. Insud Pharma S.L Company Information
 Table 76. Insud Pharma S.L Description and Business Overview
 Table 77. Insud Pharma S.L Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Insud Pharma S.L Testosterone Replacement Injectables Product
 Table 79. Insud Pharma S.L Recent Developments/Updates
 Table 80. AbbVie Inc Company Information
 Table 81. AbbVie Inc Description and Business Overview
 Table 82. AbbVie Inc Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. AbbVie Inc Testosterone Replacement Injectables Product
 Table 84. AbbVie Inc Recent Developments/Updates
 Table 85. Acrux Ltd Company Information
 Table 86. Acrux Ltd Description and Business Overview
 Table 87. Acrux Ltd Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Acrux Ltd Testosterone Replacement Injectables Product
 Table 89. Acrux Ltd Recent Developments/Updates
 Table 90. Besins Healthcare SA Company Information
 Table 91. Besins Healthcare SA Description and Business Overview
 Table 92. Besins Healthcare SA Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Besins Healthcare SA Testosterone Replacement Injectables Product
 Table 94. Besins Healthcare SA Recent Developments/Updates
 Table 95. Pfizer Inc Company Information
 Table 96. Pfizer Inc Description and Business Overview
 Table 97. Pfizer Inc Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Pfizer Inc Testosterone Replacement Injectables Product
 Table 99. Pfizer Inc Recent Developments/Updates
 Table 100. Acerus Pharmaceuticals Corporation Company Information
 Table 101. Acerus Pharmaceuticals Corporation Description and Business Overview
 Table 102. Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Acerus Pharmaceuticals Corporation Testosterone Replacement Injectables Product
 Table 104. Acerus Pharmaceuticals Corporation Recent Developments/Updates
 Table 105. Amneal Pharmaceuticals Inc Company Information
 Table 106. Amneal Pharmaceuticals Inc Description and Business Overview
 Table 107. Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Amneal Pharmaceuticals Inc Testosterone Replacement Injectables Product
 Table 109. Amneal Pharmaceuticals Inc Recent Developments/Updates
 Table 110. Biote Medical LLC Company Information
 Table 111. Biote Medical LLC Description and Business Overview
 Table 112. Biote Medical LLC Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Biote Medical LLC Testosterone Replacement Injectables Product
 Table 114. Biote Medical LLC Recent Developments/Updates
 Table 115. Endo International Plc Company Information
 Table 116. Endo International Plc Description and Business Overview
 Table 117. Endo International Plc Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Endo International Plc Testosterone Replacement Injectables Product
 Table 119. Endo International Plc Recent Developments/Updates
 Table 120. Eli lilly Company Information
 Table 121. Eli lilly Description and Business Overview
 Table 122. Eli lilly Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Eli lilly Testosterone Replacement Injectables Product
 Table 124. Eli lilly Recent Developments/Updates
 Table 125. Actavis (Allergan) Company Information
 Table 126. Actavis (Allergan) Description and Business Overview
 Table 127. Actavis (Allergan) Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Actavis (Allergan) Testosterone Replacement Injectables Product
 Table 129. Actavis (Allergan) Recent Developments/Updates
 Table 130. Bayer Company Information
 Table 131. Bayer Description and Business Overview
 Table 132. Bayer Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Bayer Testosterone Replacement Injectables Product
 Table 134. Bayer Recent Developments/Updates
 Table 135. Novartis Company Information
 Table 136. Novartis Description and Business Overview
 Table 137. Novartis Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Novartis Testosterone Replacement Injectables Product
 Table 139. Novartis Recent Developments/Updates
 Table 140. Teva Company Information
 Table 141. Teva Description and Business Overview
 Table 142. Teva Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Teva Testosterone Replacement Injectables Product
 Table 144. Teva Recent Developments/Updates
 Table 145. Mylan Company Information
 Table 146. Mylan Description and Business Overview
 Table 147. Mylan Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Mylan Testosterone Replacement Injectables Product
 Table 149. Mylan Recent Developments/Updates
 Table 150. Upsher-Smith Company Information
 Table 151. Upsher-Smith Description and Business Overview
 Table 152. Upsher-Smith Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Upsher-Smith Testosterone Replacement Injectables Product
 Table 154. Upsher-Smith Recent Developments/Updates
 Table 155. Ferring Pharmaceuticals Company Information
 Table 156. Ferring Pharmaceuticals Description and Business Overview
 Table 157. Ferring Pharmaceuticals Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Ferring Pharmaceuticals Testosterone Replacement Injectables Product
 Table 159. Ferring Pharmaceuticals Recent Developments/Updates
 Table 160. Kyowa Kirin Company Information
 Table 161. Kyowa Kirin Description and Business Overview
 Table 162. Kyowa Kirin Testosterone Replacement Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Kyowa Kirin Testosterone Replacement Injectables Product
 Table 164. Kyowa Kirin Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Testosterone Replacement Injectables Distributors List
 Table 168. Testosterone Replacement Injectables Customers List
 Table 169. Testosterone Replacement Injectables Market Trends
 Table 170. Testosterone Replacement Injectables Market Drivers
 Table 171. Testosterone Replacement Injectables Market Challenges
 Table 172. Testosterone Replacement Injectables Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Testosterone Replacement Injectables
 Figure 2. Global Testosterone Replacement Injectables Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Testosterone Replacement Injectables Market Share by Type: 2025 & 2032
 Figure 4. Testosterone Undecanoate Product Picture
 Figure 5. Testosterone Cypionate Product Picture
 Figure 6. Testosterone Enanthate Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Testosterone Replacement Injectables Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Testosterone Replacement Injectables Market Share by Application: 2025 & 2032
 Figure 10. Hospital
 Figure 11. Clinics
 Figure 12. Others
 Figure 13. Global Testosterone Replacement Injectables Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Testosterone Replacement Injectables Market Size (US$ Million), 2021–2032
 Figure 15. Global Testosterone Replacement Injectables Sales (K Units), 2021–2032
 Figure 16. Global Testosterone Replacement Injectables Average Price (US$/Unit), 2021–2032
 Figure 17. Testosterone Replacement Injectables Report Years Considered
 Figure 18. Testosterone Replacement Injectables Sales Share by Manufacturers in 2025
 Figure 19. Global Testosterone Replacement Injectables Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Testosterone Replacement Injectables Players: Market Share by Revenue in Testosterone Replacement Injectables in 2025
 Figure 21. Testosterone Replacement Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Testosterone Replacement Injectables Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Testosterone Replacement Injectables Sales Market Share by Country (2021–2032)
 Figure 24. North America Testosterone Replacement Injectables Revenue Market Share by Country (2021–2032)
 Figure 25. United States Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Testosterone Replacement Injectables Sales Market Share by Country (2021–2032)
 Figure 28. Europe Testosterone Replacement Injectables Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Testosterone Replacement Injectables Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Testosterone Replacement Injectables Revenue Market Share by Region (2021–2032)
 Figure 36. China Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Testosterone Replacement Injectables Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Testosterone Replacement Injectables Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Testosterone Replacement Injectables Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Testosterone Replacement Injectables Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Testosterone Replacement Injectables Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Testosterone Replacement Injectables by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Testosterone Replacement Injectables by Type (2021–2032)
 Figure 56. Global Testosterone Replacement Injectables Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Testosterone Replacement Injectables by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Testosterone Replacement Injectables by Application (2021–2032)
 Figure 59. Global Testosterone Replacement Injectables Price (US$/Unit) by Application (2021–2032)
 Figure 60. Testosterone Replacement Injectables Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS